Interpretability and Minimal Important Change of the Greek Quality of Life in Hand Eczema Questionnaire ( <scp>QOLHEQ</scp> )

The Quality of Life in Hand Eczema Questionnaire (QOLHEQ) is a hand eczema (HE) specific instrument used to assess health-related Quality of Life (HRQOL) in four subdomains [1]. The QOLHEQ is available in 10 language versions; one international and five national validation studies have already been published [1-6]. Score banding and minimal important change (MIC) have not been established yet for the Greek version of the QOLHEQ. We investigated the interpretability and minimal important change (MIC) of the Greek version of the QOLHEQ. The QOLHEQ was used together with a global anchor question as well as four anchors specific to the four QOLHEQ subdomains (according to [7]) in a longitudinal manner at (i) baseline, (ii) after 1–3 days (stable HE), and (iii) after 4–6 weeks (HE changed). Change in HE severity was assessed using a patient-reported global rating of change scale. Cohen's weighted kappa was used to identify optimal score bands for the total QOLHEQ score and its subscales. Symptoms: 0–2, 3–7, 8–13, 14–20 and ≥ 21. Emotions: 0–3, 4–10, 10–15, 16–20 and ≥ 21. Functioning: 0–3, 4–12, 13–15, 16–21 and ≥ 22. Treatment and prevention: 0–3, 4–7, 8–15, 16–22 and ≥ 23. The minimal important change (MIC) was determined through anchor- and distribution-based methods, with a total score MIC identified as 7.0 points while the smallest detectable change was 5.6 points. Subscale-specific MIC (SDC) values were as follows: symptoms 1.7 (1.6), emotions 2.3 (1.9), functioning 3.1 (2.3) as well as treatment and prevention 1.9 (1.6). Our findings provide practical thresholds for interpreting the Greek QOLHEQ scores, enabling clinicians and researchers to more clearly assess the severity of HRQOL impairment. The established MIC facilitates the evaluation of meaningful clinical changes in patients' conditions, thus improving patient management and enhancing comparability with international studies. Our results indicate that scores from the Greek QOLHEQ version can be interpreted very similarly to the Dutch [3] and German [1] language versions, where banding studies have already been performed. Compared to other versions, the Greek MIC is much lower. The study was conducted at the University Hospital of Heraklion, Crete, with mostly fishermen, agricultural workers and nurses in our sample. The lower MIC may reflect a more homogeneous patient group with similar aetiology and prognosis. Open Access funding enabled and organized by Projekt DEAL. R.F.O. and D.K. declare no conflicts of interest. C.A. received institutional funding from Bionorica SE and Dr. Wolff Group and consultancy fees from EFCNI, Bionorica SE, Dr. Wolff Group, Rheacell, Sanofi, Pfizer, LEOPharma and Incyte. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Authors

Institutions

Publication Details

Journal
Contact Dermatitis
Published
2025-08-12
DOI
https://doi.org/10.1111/cod.70006
Citations
1
Primary Topic
Contact Dermatitis and Allergies
Type
article
Field-Weighted Citation Impact
2.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interpretability and Minimal Important Change of the Greek Quality of Life in Hand Eczema Questionnaire ( QOLHEQ )

Dimitra Koumaki, Robert Ofenloch, Christian Apfelbacher
1 citations
Contact Dermatitis
Contact Dermatitis and Allergies
2.00
article

Interpretability and Minimal Important Change of the Greek Quality of Life in Hand Eczema Questionnaire ( QOLHEQ )

Dimitra Koumaki, Robert Ofenloch, Christian Apfelbacher
article en
1 citations

Abstract

The Quality of Life in Hand Eczema Questionnaire (QOLHEQ) is a hand eczema (HE) specific instrument used to assess health-related Quality of Life (HRQOL) in four subdomains [1]. The QOLHEQ is available in 10 language versions; one international and five national validation studies have already been published [1-6]. Score banding and minimal important change (MIC) have not been established yet for the Greek version of the QOLHEQ. We investigated the interpretability and minimal important change (MIC) of the Greek version of the QOLHEQ. The QOLHEQ was used together with a global anchor question as well as four anchors specific to the four QOLHEQ subdomains (according to [7]) in a longitudinal manner at (i) baseline, (ii) after 1–3 days (stable HE), and (iii) after 4–6 weeks (HE changed). Change in HE severity was assessed using a patient-reported global rating of change scale. Cohen's weighted kappa was used to identify optimal score bands for the total QOLHEQ score and its subscales. Symptoms: 0–2, 3–7, 8–13, 14–20 and ≥ 21. Emotions: 0–3, 4–10, 10–15, 16–20 and ≥ 21. Functioning: 0–3, 4–12, 13–15, 16–21 and ≥ 22. Treatment and prevention: 0–3, 4–7, 8–15, 16–22 and ≥ 23. The minimal important change (MIC) was determined through anchor- and distribution-based methods, with a total score MIC identified as 7.0 points while the smallest detectable change was 5.6 points. Subscale-specific MIC (SDC) values were as follows: symptoms 1.7 (1.6), emotions 2.3 (1.9), functioning 3.1 (2.3) as well as treatment and prevention 1.9 (1.6). Our findings provide practical thresholds for interpreting the Greek QOLHEQ scores, enabling clinicians and researchers to more clearly assess the severity of HRQOL impairment. The established MIC facilitates the evaluation of meaningful clinical changes in patients' conditions, thus improving patient management and enhancing comparability with international studies. Our results indicate that scores from the Greek QOLHEQ version can be interpreted very similarly to the Dutch [3] and German [1] language versions, where banding studies have already been performed. Compared to other versions, the Greek MIC is much lower. The study was conducted at the University Hospital of Heraklion, Crete, with mostly fishermen, agricultural workers and nurses in our sample. The lower MIC may reflect a more homogeneous patient group with similar aetiology and prognosis. Open Access funding enabled and organized by Projekt DEAL. R.F.O. and D.K. declare no conflicts of interest. C.A. received institutional funding from Bionorica SE and Dr. Wolff Group and consultancy fees from EFCNI, Bionorica SE, Dr. Wolff Group, Rheacell, Sanofi, Pfizer, LEOPharma and Incyte. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Contact DermatitisVol. 93(5)
Heidelberg University (DE), University Hospital Heidelberg (DE), University Hospital of Heraklion (GR), Otto-von-Guericke-Universität Magdeburg (DE)
Openalex Percentile: Top 13%
Contact Dermatitis and Allergies
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.